Protease-activated receptors as therapeutic targets in visceral pain

Current Neuropharmacology

Volumn 11, Issue 6, 2013, Pages 598-605

  Cenac, Nicolas ^a,b,c  

^a INSERM   (France)

^b CNRS   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Calcium channels; IBD; IBS; Inflammation; Neuromediators; Pain; Protease; Protease activated receptor

Indexed keywords

BLOOD CLOTTING FACTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; PROENKEPHALIN; PROTEIN FOS; PROTEINASE ACTIVATED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; SERINE PROTEINASE; SEROTONIN RECEPTOR; THROMBIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 4;

ALLODYNIA; ARTICLE; CALCIUM SIGNALING; CROHN DISEASE; CYSTITIS; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; HUMAN; HYPERALGESIA; IRRITABLE COLON; MAST CELL DEGRANULATION; MECHANICAL HYPERALGESIA; NONHUMAN; PANCREATITIS; QUALITY OF LIFE; SIGNAL TRANSDUCTION; SPINAL GANGLION; ULCERATIVE COLITIS; VISCERAL PAIN;

EID: 84899574231     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X113119990039     Document Type: Article

References (72)

1. Thompson, W. G. The road to Rome. Gut, 1999, 45 Suppl 2, II80.
2. Davis, M. P. Drug management of visceral pain: concepts from basic research. Pain Res. Treat., 2012, 2012, 265605.
3. Vergnolle, N. Visceral afferents: what role in post-inflammatory pain? Auton Neurosci., 2010, 153, 79-83.
4. Cenac, N.: Proteases and Inflammatory Pain. In: Proteases and Their Receptors in Inflammation. Edited by Vergnolle N, Chignard M: Springer Basel; 2011, 253-274.
5. Vergnolle, N. Review article: proteinase-activated receptors-novel signals for gastrointestinal pathophysiology. Aliment. Pharmacol. Ther., 2000, 14, 257-266.
6. Vergnolle, N.; Ferazzini, M.; D'Andrea, M. R.; Buddenkotte, J.; Steinhoff, M. Proteinase-activated receptors: novel signals for peripheral nerves. Trends Neurosci., 2003, 26, 496-500.
7. Hollenberg, M. D. Protease-mediated signalling: new paradigms for cell regulation and drug development. Trends Pharmacol. Sci., 1996, 17, 3-6.
8. Hollenberg, M. D.; Compton, S. J. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. Pharmacol. Rev., 2002, 54, 203-217.
9. Bunnett, N. W. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin. Thromb. Hemost., 2006, 32 Suppl 1, 39-48.
10. Nakanishi-Matsui, M.; Zheng, Y. W.; Sulciner, D. J.; Weiss, E. J.; Ludeman, M. J.; Coughlin, S. R. PAR3 is a cofactor for PAR4 activation by thrombin. Nature, 2000, 404, 609-613.
11. Vergnolle, N. Protease-activated receptors as drug targets in inflammation and pain. Pharmacol. Ther., 2009, 123, 292-309.
12. Hoogerwerf, W. A.; Zou, L.; Shenoy, M.; Sun, D.; Micci, M. A.; Lee-Hellmich, H.; Xiao, S. Y.; Winston, J. H.; Pasricha, P. J. The proteinase-activated receptor 2 is involved in nociception. J Neurosci., 2001, 21, 9036-9042.
13. Hoogerwerf, W. A.; Shenoy, M.; Winston, J. H.; Xiao, S. Y.; He, Z.; Pasricha, P. J. Trypsin mediates nociception via the proteinase-activated receptor 2: a potentially novel role in pancreatic pain. Gastroenterology, 2004, 127, 883-891.
14. Ceppa, E. P.; Lyo, V.; Grady, E. F.; Knecht, W.; Grahn, S.; Peterson, A.; Bunnett, N. W.; Kirkwood, K. S.; Cattaruzza, F. Serine proteases mediate inflammatory pain in acute pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol., 2011, 300, G1033-1042.
15. Dattilio, A.; Vizzard, M. A. Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers. J. Urol., 2005, 173, 635-639.
16. D'Andrea, M. R.; sabam, M. R.; Nguyen, N. B.; Andrade-Gordon, P.; Saban, R. Overriding participation of protease activated receptor (PAR)s 1, 2, 3, and 4 in experimental bladder inflammation. Am. J. Pathol., 2003, 162, 907-923.
17. Shimizu, N.; Nakahara, T.; Saito, M.; Ishii, K. Role of capsaicin-sensitive sensory nerves in protease-activated receptor-2-mediated contraction of rat urinary bladder. Eur. J. Pharmacol., 2007, 569, 145-148.
18. Kawabata, A.; Kuroda, R.; Nishida, M.; Nagata, N.; Sakaguchi, Y.; Kawao, N.; Nishikawa, H.; Arizono, N.; Kawai, K. Protease-activated receptor-2 (PAR-2) in the pancreas and parotid gland: Immunolocalization and involvement of nitric oxide in the evoked amylase secretion. Life Sci., 2002, 71, 2435-2446.
19. Coelho, A. M.; Vergnolle, N.; Guiard, B.; Fioramonti, J.; Bueno, L. Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats. Gastroenterology, 2002, 122 1035-1047.
20. Vergnolle, N.; Bunnett, N. W.; Sharkey, K. A.; Brussee, V.; Compton, S. J.; Grady, E. F.; Cirino, G.; Gerard, N.; Basbaum, A. I.; Andrade-Gordon, P.; Hollenberg, M. D.; Wallace, J. L. Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat. Med., 2001, 7, 821-826.
21. Asfaha, S.; Brussee, V.; Chapman, K.; Zochodne, D. W.; Vergnolle, N. Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli. Br. J. Pharmacol., 2002, 135, 1101-1106.
22. Bar-Shavit, R.; Kahn, A.; Mudd, M. S.; Wilner, G. D.; Mann, K. G.; Fenton, J. W. Localization of a chemotactic domain in human thrombin. Biochemistry, 1984, 23, 397-400.
23. Bar-Shavit, R.; Kahn, A.; Wilner, G. D.; Fenton, J. W. Monocyte chemotaxis: stimulation by specific exosite region in thrombin. Science, 1983, 220, 728-731.
24. Herbert, J. M.; Dupuy, E.; Laplace, M. C.; Zini, J. M.; Bar-Shavit, R.; Tobelem, G. Thrombin induces endothelial cell growth via both a proteolytic and non-proteolytic pathway. Biochem. J, 1994, 303, 227-231.
25. Martin, L.; Auge, C.; Boue, J.; Buresi, M. C.; Chapman, K.; Asfaha, S.; Andrade-Gordon, P.; Steinhoff, M.; Cenac, N.; Dietrich, G.; Vergnolle, N. Thrombin receptor: An endogenous inhibitor of inflammatory pain, activating opioid pathways. Pain, 2009, 146, 121-129.
26. de Garavilla, L.; Vergnolle, N.; Young, S. H.; Ennes, H.; Steinhoff, M.; Ossovskaya, V. S.; D'Andrea, M. R.; Mayer, E. A.; Wallace, J. L.; Hollenberg, M. D.; Andrade-Gordon, P.; Bunnett, N. W. Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br. J. Pharmacol., 2001, 133, 975-987.
27. Jaume, M.; Laffont, S.; Chapey, E.; Blanpied, C.; Dietrich, G. Opioid receptor blockade increases the number of lymphocytes without altering T cell response in draining lymph nodes in vivo. J. Neuroimmunol., 2007, 188, 95-102.
28. Nissen, J. B.; Kragballe, K. Enkephalins modulate differentiation of normal human keratinocytes in vitro. Exp. Dermatol., 1997, 6, 222-229.
29. Bottger, A.; Spruce, B. A. Proenkephalin is a nuclear protein responsive to growth arrest and differentiation signals. J.Cell Biol., 1995, 130, 1251-1262.
30. Asfaha, S.; Cenac, N.; Houle, S.; Altier, C.; Papez, M. D.; Nguyen, C.; Steinhoff, M.; Chapman, K.; Zamponi, G. W.; Vergnolle, N. Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br. J. Pharmacol., 2007, 150, 176-185.
31. Auge, C.; Balz-Hara, D.; Steinhoff, M.; Vergnolle, N.; Cenac, N. Protease-activated receptor-4 (PAR 4): a role as inhibitor of visceral pain and hypersensitivity. Neurogastroenterol. Motil., 2009, 21, 1189-e1107.
32. Karanjia, R.; Spreadbury, I.; Bautista-Cruz, F.; Tsang, M. E.; Vanner, S. Activation of protease-activated receptor-4 inhibits the intrinsic excitability of colonic dorsal root ganglia neurons. Neurogastroenterol.Motil., 2009, 21, 1218-1221.
33. Laird, J. M.; Martinez-Caro, L.; Garcia-Nicas, E.; Cervero, F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain, 2001, 92, 335-342.
34. Salzmann, J. L.; Peltier-Koch, F.; Bloch, F.; Petite, J. P.; Camilleri, J. P. Morphometric study of colonic biopsies: a new method of estimating inflammatory diseases. Lab. Invest., 1989, 60, 847-851.
35. Barbara, G.; Stanghellini, V.; De, G. R.; Cremon, C.; Cottrell, G. S.; Santini, D.; Pasquinelli, G.; Morselli-Labate, A. M.; Grady, E. F.; Bunnett, N. W.; Collins, S. M.; Corinaldesi, R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology, 2004, 126, 693-702.
36. Barbara, G.; Wang, B.; Stanghellini, V.; De, G. R.; Cremon, C.; Di, N. G.; Trevisani, M.; Campi, B.; Geppetti, P.; Tonini, M.; Bunnett, N. W.; Grundy, D.; Corinaldesi, R. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology, 2007, 132, 26-37.
37. Klooker, T. K.; Braak, B.; Koopman, K. E.; Welting, O.; Wouters, M. M.; van der Heide, S.; Schemann, M.; Bischoff, S. C.; van den Wijngaard, R. M.; Boeckxstaens, G. E. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut, 2010, 59, 1213-1221.
38. Cenac, N.; Andrews, C. N.; Holzhausen, M.; Chapman, K.; Cottrell, G.; ndrade-Gordon, P.; Steinhoff, M.; Barbara, G.; Beck, P.; Bunnett, N. W.; Sharkey, K. A.; Ferraz, J. G.; Shaffer, E.; Vergnolle, N. Role for protease activity in visceral pain in irritable bowel syndrome. J. Clin. Invest., 2007, 117, 636-647.
39. Kerckhoffs, A. P.; Ter Linde, J. J.; Akkermans, L. M.; Samsom, M. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol. Motil., 2008, 20, 900-907.
40. Buhner, S.; Li, Q.; Vignali, S.; Barbara, G.; De Giorgio, R.; Stanghellini, V.; Cremon, C.; Zeller, F.; Langer, R.; Daniel, H.; Michel, K.; Schemann, M. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology, 2009, 137, 1425-1434.
41. Mueller, K.; Michel, K.; Krueger, D.; Demir, I. E.; Ceyhan, G. O.; Zeller, F.; Kreis, M. E.; Schemann, M. Activity of protease-activated receptors in the human submucous plexus. Gastroenterology, 2011, 141, 2088-2097 e2081.
42. Kugler, E. M.; Mazzuoli, G.; Demir, I. E.; Ceyhan, G. O.; Zeller, F.; Schemann, M. Activity of protease-activated receptors in primary cultured human myenteric neurons. Front. Neurosci., 2012, 6, 133.
43. Motta, J. P.; Magne, L.; Descamps, D.; Rolland, C.; Squarzoni-Dale, C.; Rousset, P.; Martin, L.; Cenac, N.; Balloy, V.; Huerre, M.; Frohlich, L. F.; Jenne, D.; Wartelle, J.; Belaaouaj, A.; Mas, E.; Vinel, J. P.; Alric, L.; Chignard, M.; Vergnolle, N.; Sallenave, J. M. Modifying the protease, antiprotease pattern by elafin overexpression protects mice from colitis. Gastroenterology, 2011, 140, 1272-1282.
44. Bustos, D.; Negri, G.; De Paula, J. A.; Di Carlo, M.; Yapur, V.; Facente, A.; De Paula, A. Colonic proteinases: increased activity in patients with ulcerative colitis. Medicina (B Aires), 1998, 58, 262-264.
45. Playford, R. J.; Hanby, A. M.; Patel, K.; Calam, J. Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon. Am. J. Pathol., 1995, 146, 310-316.
46. Tarlton, J. F.; Whiting, C. V.; Tunmore, D.; Bregenholt, S.; Reimann, J.; Claesson, M. H.; Bland, P. W. The role of up-regulated serine proteases and matrix metalloproteinases in the pathogenesis of a murine model of colitis. Am. J. Pathol., 2000, 157, 1927-1935.
47. Raithel, M.; Winterkamp, S.; Pacurar, A.; Ulrich, P.; Hochberger, J.; Hahn, E. G. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand. J. Gastroenterol., 2001, 36, 174-179.
48. Luthen, R.; Niederau, C.; Grendell, J. H. Intrapancreatic zymogen activation and levels of ATP and glutathione during caerulein pancreatitis in rats. Am. J. Physiol., 1995, 268, G592-604.
49. Motta, J. P.; Bermudez-Humaran, L. G.; Deraison, C.; Martin, L.; Rolland, C.; Rousset, P.; Boue, J.; Dietrich, G.; Chapman, K.; Kharrat, P.; Vinel, J. P.; Alric, L.; Mas, E.; Sallenave, J. M.; Langella, P.; Vergnolle, N. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci. Transl. Med., 2012, 4, 158ra144.
50. Cattaruzza, F.; Lyo, V.; Jones, E.; Pham, D.; Hawkins, J.; Kirkwood, K.; Valdez-Morales, E.; Ibeakanma, C.; Vanner, S. J.; Bogyo, M.; Bunnett, N. W. Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice. Gastroenterology, 2011, 141, 1864-1874 e1861-1863.
51. Weston, A. P.; Biddle, W. L.; Bhatia, P. S.; Miner, P. B., Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig. Dis. Sci., 1993, 38, 1590-1595.
52. O'Sullivan, M.; Clayton, N.; Breslin, N. P.; Harman, I.; Bountra, C.; McLaren, A.; O'Morain, C. A. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol. Motil., 2000, 12, 449-457.
53. Park, C. H.; Joo, Y. E.; Choi, S. K.; Rew, J. S.; Kim, S. J.; Lee, M. C. Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome. J. Korean Med. Sci., 2003, 18, 204-210.
54. La, J. H.; Kim, T. W.; Sung, T. S.; Kang, J. W.; Kim, H. J.; Yang, I. S. Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis. World J. Gastroenterol.,2003, 9, 2791-2795.
55. La, J. H.; Kim, T. W.; Sung, T. S.; Kim, H. J.; Kim, J. Y.; Yang, I. S. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. J. Vet. Sci., 2004, 5, 319-324.
56. Lourbakos, A.; Yuan, Y. P.; Jenkins, A. L.; Travis, J.; Andrade-Gordon, P.; Santulli, R.; Potempa, J.; Pike, R. N. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: a new trait in microbial pathogenicity. Blood, 2001, 97, 3790-3797.
57. Ibeakanma, C.; Ochoa-Cortes, F.; Miranda-Morales, M.; McDonald, T.; Spreadbury, I.; Cenac, N.; Cattaruzza, F.; Hurlbut, D.; Vanner, S.; Bunnett, N.; Vergnolle, N. Brain-gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndrome. Gastroenterology, 2011, 141, 2098-2108 e2095.
58. Caterina, M. J.; Schumacher, M. A.; Tominaga, M.; Rosen, T. A.; Levine, J. D.; Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 1997, 389, 816-824.
59. Julius, D.; Basbaum, A. I. Molecular mechanisms of nociception. Nature, 2001, 413, 203-210.
60. Amadesi, S.; Nie, J.; Vergnolle, N.; Cottrell, G. S.; Grady, E. F.; Trevisani, M.; Manni, C.; Geppetti, P.; McRoberts, J. A.; Ennes, H.; Davis, J. B.; Mayer, E. A.; Bunnett, N. W. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J. Neurosci., 2004, 24, 4300-4312.
61. Dai, Y.; Moriyama, T.; Higashi, T.; Togashi, K.; Kobayashi, K.; Yamanaka, H.; Tominaga, M.; Noguchi, K. Proteinase-activated receptor 2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for proteinase-induced inflammatory pain. J. Neurosci., 2004, 24, 4293-4299.
62. Kawao, N.; Shimada, C.; Itoh, H.; Kuroda, R.; Kawabata, A. Capsazepine inhibits thermal hyperalgesia but not nociception triggered by protease-activated receptor-2 in rats. Jpn. J. Pharmacol., 2002, 89, 184-187.
63. Kawao, N.; Ikeda, H.; Kitano, T.; Kuroda, R.; Sekiguchi, F.; Kataoka, K.; Kamanaka, Y.; Kawabata, A. Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2. J. Pharmacol. Sci., 2004, 94, 277-285.
64. Amadesi, S.; Cottrell, G. S.; Divino, L.; Chapman, K.; Grady, E. F.; Bautista, F.; Karanjia, R.; Barajas-Lopez, C.; Vanner, S.; Vergnolle, N.; Bunnett, N. W. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase C-(epsilon) and A-dependent mechanisms in rats and mice. J. Physiol., 2006, 575(Pt2), 555-71.
65. Cenac, N.; Altier, C.; Chapman, K.; Liedtke, W.; Zamponi, G.; Vergnolle, N. Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms. Gastroenterology, 2008, 135, 937-946, 946 e931-932.
66. Grant, A. D.; Cottrell, G. S.; Amadesi, S.; Trevisani, M.; Nicoletti, P.; Materazzi, S.; Altier, C.; Cenac, N.; Zamponi, G. W.; Bautista-Cruz, F.; Lopez, C. B.; Joseph, E. K.; Levine, J. D.; Liedtke, W.; Vanner, S.; Vergnolle, N.; Geppetti, P.; Bunnett, N. W. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol., 2007, 578, 715-733.
67. Cattaruzza, F.; Spreadbury, I.; Miranda-Morales, M.; Grady, E. F.; Vanner, S. J.; Bunnett, N. W. Transient Receptor Potential Ankyrin-1 has a Major Role in Mediating Visceral Pain in Mice. Am. J. Physiol Gastrointest. Liver Physiol., 2009, 298(1),G81-91.
68. Dai, Y.; Wang, S.; Tominaga, M.; Yamamoto, S.; Fukuoka, T.; Higashi, T.; Kobayashi, K.; Obata, K.; Yamanaka, H.; Noguchi, K. Sensitization of TRPA1 by PAR2 contributes to the sensation of inflammatory pain. J. Clin. Invest, 2007, 117, 1979-1987.
69. Cenac, N.; Altier, C.; Motta, J. P.; d'Aldebert, E.; Galeano, S.; Zamponi, G. W.; Vergnolle, N. Potentiation of TRPV4 signalling by histamine and serotonin: an important mechanism for visceral hypersensitivity. Gut, 2010, 59, 481-488.
70. Brierley, S. M.; Page, A. J.; Hughes, P. A.; Adam, B.; Liebregts, T.; Cooper, N. J.; Holtmann, G.; Liedtke, W.; Blackshaw, L. A. Selective role for TRPV4 ion channels in visceral sensory pathways. Gastroenterology, 2008, 134, 2059-2069.
71. Brierley, S. M.; Hughes, P. A.; Page, A. J.; Kwan, K. Y.; Martin, C. M.; O'Donnell, T. A.; Cooper, N. J.; Harrington, A. M.; Adam, B.; Liebregts, T.; Holtmann, G.; Corey, D. P.; Rychkov, G. Y.; Blackshaw, L. A. The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology, 2009, 137, 2084-2095 e2083.
72. Poole, D. P.; Amadesi, S.; Veldhuis, N. A.; Abogadie, F. C.; Lieu, T.; Darby, W.; Liedtke, W.; Lew, M. J.; McIntyre, P.; Bunnett, N. W. Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) Coupling is Required for Sustained Inflammatory Signaling. J. Biol. Chem., 2013, 288(8), 5790-802.